Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00519584 · ClinicalTrials.gov registry record · NA
Interscalene Nerve Blocks With Ropivacaine Alone, With Dexamethasone, Plus Systemic Dexamethasone
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 218
- Enrollment target
NCT00519584 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 218 participants.
The verdict
NCT00519584, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 218 participants
- Enrollment target
Study Summary
This study will test the hypothesis that ropivacaine in combination with either systemic or local steroid provides comparably longer-lasting analgesia tha ropivacaine alone.
Interventions
- DRUG Bupivacaine
- DRUG Saline
- DRUG Ropivacaine
- DRUG dex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00519584
The ClinicalTrials.gov registry entry for NCT00519584 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 218 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Bupivacaine is the first listed.
NCT00519584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00519584 about?
NCT00519584 is a clinical study titled "Interscalene Nerve Blocks With Ropivacaine Alone, With Dexamethasone, Plus Systemic Dexamethasone". This study will test the hypothesis that ropivacaine in combination with either systemic or local steroid provides comparably longer-lasting analgesia tha ropivacaine alone.
What is the current status of trial NCT00519584?
This trial is currently terminated. It is a NA study. The enrollment target is 218 participants. The study started on 2007-07. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00519584?
The interventions under investigation include: Bupivacaine (DRUG), Saline (DRUG), Ropivacaine (DRUG), dex (DRUG).
Who is sponsoring clinical trial NCT00519584?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.